← Back to Screener
BioHarvest Sciences Inc. Common Stock (BHST)
Price$4.42
Favorite Metrics
Price vs S&P 500 (26W)-21.65%
Price vs S&P 500 (4W)-11.69%
Market Capitalization$115.99M
All Metrics
Book Value / Share (Quarterly)$0.24
Revenue Growth (3Y)217.48%
Cash Flow / Share (Quarterly)$-0.58
Price vs S&P 500 (YTD)0.00%
Gross Margin (TTM)54.00%
Net Profit Margin (TTM)-76.65%
EPS (TTM)$-1.19
10-Day Avg Trading Volume0.00M
EPS Excl Extra (TTM)$-1.19
EPS (Annual)$-0.93
ROI (Annual)-178.22%
Gross Margin (Annual)44.45%
Cash / Share (Quarterly)$0.16
Revenue Growth QoQ (YoY)101.88%
ROA (Last FY)-96.27%
Revenue Growth TTM (YoY)111.68%
EBITD / Share (TTM)$-0.44
Operating Margin (TTM)-35.00%
Cash Flow / Share (Annual)$-0.02
P/B Ratio28.02x
P/B Ratio (Quarterly)32.45x
EV / Revenue (TTM)5.52x
Net Interest Coverage (TTM)-11.14x
ROA (TTM)-85.16%
EPS Incl Extra (Annual)$-0.93
Current Ratio (Annual)1.94x
Quick Ratio (Quarterly)0.48x
3-Month Avg Trading Volume0.00M
52-Week Price Return-46.88%
Tangible BV / Share (Quarterly)$-0.02
P/S Ratio (Annual)9.15x
Asset Turnover (Annual)0.21x
52-Week High$8.05
EPS Excl Extra (Annual)$-0.93
26-Week Price Return-20.93%
Quick Ratio (Annual)1.62x
Total Debt / Equity (Annual)0.93x
Current Ratio (Quarterly)0.80x
Enterprise Value$123.914
Asset Turnover (TTM)1.11x
Inventory Turnover (Annual)3.71x
Pretax Margin (Annual)-99.15%
Cash / Share (Annual)$0.01
ROE (Last FY)-344.20%
Net Interest Coverage (Annual)-0.58x
EPS Basic Excl Extra (Annual)$-0.93
Receivables Turnover (TTM)14.40x
Total Debt / Equity (Quarterly)2.58x
EPS Incl Extra (TTM)$-1.19
Receivables Turnover (Annual)4.32x
ROI (TTM)-21.15%
P/S Ratio (TTM)5.17x
Revenue / Share (Annual)$0.94
Tangible BV / Share (Annual)$-0.02
Price vs S&P 500 (52W)-46.24%
Year-to-Date Return0.00%
5-Day Price Return-0.63%
EPS Normalized (Annual)$-0.93
Net Profit Margin (Annual)-99.15%
Month-to-Date Return0.00%
Cash Flow / Share (TTM)$-0.03
EBITD / Share (Annual)$-0.82
Operating Margin (Annual)-78.65%
EPS Basic Excl Extra (TTM)$-1.19
P/B Ratio (Annual)73.09x
Inventory Turnover (TTM)3.92x
Pretax Margin (TTM)-76.65%
Book Value / Share (Annual)$0.01
Price vs S&P 500 (13W)-1.33%
Beta-0.34x
Revenue / Share (TTM)$1.29
ROE (TTM)-62.28%
52-Week Low$7.95
Analyst Recommendations
Jan 2025
Feb 2025
Mar 2025
Apr 2025
4.14
4.13
4.13
4.13
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
BHSTBioHarvest Sciences Inc. Common Stock | 5.17x | 111.68% | 54.00% | — | $4.42 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
BioHarvest Sciences owns patented technology for large-scale plant cell cultivation that produces active plant ingredients directly, without growing whole plants. The company operates across two segments: nutraceuticals such as dietary supplements and botanical-derived Active Pharmaceutical Ingredients for therapeutic use. This platform approach offers potential advantages in production scalability and supply chain efficiency.